Based on the current understanding of HLA-G and its various forms that have multiple immune tolerance regulating functions in malignant tumors, HLA-G is generally recognized as a biomarker that can be used to monitor the disease state and progression in cancer patients (153). The gene discussed is HLA-G; the disease is cancer.